These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7136849)

  • 21. Effect of high dose alpha-tocopherol and alpha-tocopherol acetate pretreatment on adriamycin (doxorubicin) induced toxicity and tissue distribution.
    Shinozawa S; Gomita Y; Araki Y
    Physiol Chem Phys Med NMR; 1988; 20(4):329-35. PubMed ID: 3254541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
    Lee HJ; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
    Patel KJ; Trédan O; Tannock IF
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion.
    Speth PA; Linssen PC; Holdrinet RS; Haanen C
    Clin Pharmacol Ther; 1987 Jun; 41(6):661-5. PubMed ID: 3581649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of adriamycin content by a sensitive immunochemical assay.
    Citro G; Verdina A; Galati R; Floridi A
    Anticancer Res; 1988; 8(4):549-52. PubMed ID: 3178147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue concentration of doxorubicin (adriamycin) in mouse pretreated with alpha-tocopherol or coenzyme Q10.
    Shinozawa S; Gomita Y; Araki Y
    Acta Med Okayama; 1991 Jun; 45(3):195-9. PubMed ID: 1891979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and antitumour activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing mice.
    Lee SD; Park JB; Lee WI; Shim HJ; Lee ED; Lee JJ; Kim WB; Yang J; Kim CK; Lee MG
    Biopharm Drug Dispos; 1995 Aug; 16(6):489-505. PubMed ID: 7579031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition and metabolism of adriamycin octanoylhydrazone (NSC 233853) in mice and rabbits.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1981; 9(3):240-5. PubMed ID: 6113933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of regional versus systemic drug injection. Adriamycin concentration in peripheral blood and gastric stump (post-Billroth II gastrectomy) in the dog.
    P'eng FK; Wu CW; Chang TJ; Lui WY
    Cancer Chemother Pharmacol; 1989; 23(6):363-6. PubMed ID: 2713958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of doxorubicin, (2"R)-4'-O-tetrahydropyranyl-adriamycin and aclarubicin.
    Fujita H; Ogawa K; Tone H; Iguchi H; Shomura T; Murata S
    Jpn J Antibiot; 1986 May; 39(5):1321-36. PubMed ID: 3463778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A; Yamashita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
    Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
    Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of adriamycin by sarcoma transplants in the rat kidney: effects of renal arterial vs systemic constant rate infusion and of combination with ricin.
    Tvete ST; Elsayed EA; Hope A; Clausen G
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):127-34. PubMed ID: 6682770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin.
    Freeman RW; MacDonald JS; Olson RD; Boerth RC; Oates JA; Harbison RD
    Toxicol Appl Pharmacol; 1980 Jun; 54(1):168-75. PubMed ID: 7394786
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies.
    Meco D; Colombo T; Ubezio P; Zucchetti M; Zaffaroni M; Riccardi A; Faircloth G; Jose J; D'Incalci M; Riccardi R
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):131-8. PubMed ID: 12783202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of biological membrane stabilizing drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice].
    Shinozawa S; Kawasaki H; Gomita Y
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):93-8. PubMed ID: 8546477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane fluidity in Ehrlich ascites tumor cells treated with adriamycin.
    Sugiyama M; Sakanashi T; Okamoto K; Chinami M; Hidaka T; Ogura R
    Biotechnol Appl Biochem; 1986; 8(2-3):217-21. PubMed ID: 3741633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Basic study on hepatic artery chemoembolization and tumor selective drug targeting by temperature-sensitive liposome with local hyperthermia].
    Ueno M; Zou YY; Yamagishi M; Horikoshi I
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3735-8. PubMed ID: 2596857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.